We have created an explanatory video about SGD-01, a new drug under development by StaGen.
This drug discovery project is led by Naoyuki Kamatani, who previously succeeded in the world’s first gene-based drug discovery. A clinical trial for Parkinson’s disease, supported by AMED, is currently underway at Fujita Health University.

YouTube Post: SGD-01 Overview Video
https://youtu.be/vEoSRHVwHog

For further information, please contact
Mail To : Naoyuki Kamatani, M.D., Ph.D.
or
Mail To : Info StaGen Co., Ltd.